Bioiberica expands Nucleoforce range with three new products

Bioiberica, a global life science company, has unveiled three new functional ingredients within its Nucleoforce portfolio, designed to advance animal immune and intestinal health. Under the new positioning ‛Immunity Force, Life Force’, the expanded range introduces Nucleoforce Immunity, Nucleoforce Performance and Nucleoforce High Flowability (HF) – each formulated to meet growing demand for effective, ethical and science-driven nutrition solutions across pet food, livestock and aquaculture sectors.

The launch marks a new phase for Bioiberica’s nucleotide expertise. As the fundamental building blocks of DNA and RNA, nucleotides play a vital role in the development of fast-replicating tissues, such as those in the immune and intestinal systems. Originally developed to support animals during periods of stress, rapid growth or malnutrition, the Nucleoforce line now takes these benefits further. The new ingredients target immune health (Immunity), production efficiency (Performance) and growth (HF), offering food manufacturers precision-tailored solutions.

Emerging research from Bioiberica’s R&D team highlights the synergistic potential of these ingredients when combined with specific bioactive compounds. In two recent studies on Pacific white shrimp, supplementation with Nucleoforce alone improved growth performance – results that were further enhanced when paired with seaweed meal and olive extract. This combination also boosted resistance to bacterial infections, significantly increasing survival rates.

‛The potential unlocked by our team’s cutting-edge research is incredibly exciting’, commented Xavier Garcia, business unit director animal health & plant health at Bioiberica, in the press release. ‛Not only do these studies demonstrate the powerful immune- and development-supporting performance we expect from Nucleoforce, but for the first time, we can see how its effects can be further enhanced in the presence of additional bioactive compounds’. The company is planning to conduct similar studies in order to address more animal species in the future, according to Garcia.